skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Antibiotics remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)
University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)
Material Type:
Artigo 		Adicionar ao Meu Espaço

University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)

Obesity, fitness, & wellness week, 2024-01, p.5184

NewsRX LLC

Texto completo disponível

Citações Citado por
2
Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study
Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study

Nordback, Isto ; Sand, Juhani ; Saaristo, Rauni ; Paajanen, Hannu

Journal of gastrointestinal surgery, 2001-03, Vol.5 (2), p.113-119 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections

Smith, Jordan R. ; Rybak, Jeffrey M. ; Claeys, Kimberly C.

Pharmacotherapy, 2020-04, Vol.40 (4), p.343-356 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections

Heo, Young-A.

Drugs (New York, N.Y.), 2021-02, Vol.81 (3), p.377-388 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
5
Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model

Pais, Gwendolyn M. ; Marianski, Sylwia ; Valdez, Kimberly ; Melicor, Renz Paulo ; Liu, Jiajun ; Rohani, Roxane ; Chang, Jack ; Tong, Steven Y. C. ; Davis, Joshua S. ; Scheetz, Marc H.

British journal of pharmacology, 2024-03, Vol.181 (5), p.670-680 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
In Vitro Susceptibility and in Vivo Efficacy of Antimicrobials in the Treatment of Bacteroides fragilis--Escherichia coli Infection in Mice [with Discussion]
In Vitro Susceptibility and in Vivo Efficacy of Antimicrobials in the Treatment of Bacteroides fragilis--Escherichia coli Infection in Mice [with Discussion]
Material Type:
Artigo 		Adicionar ao Meu Espaço

In Vitro Susceptibility and in Vivo Efficacy of Antimicrobials in the Treatment of Bacteroides fragilis--Escherichia coli Infection in Mice [with Discussion]

Brook, Itzhak

The Journal of infectious diseases, 1989-10, Vol.160 (4), p.651-656 [Periódico revisado por pares]

United States: University of Chicago Press

Texto completo disponível

Citações Citado por
7
A case of prostatitis due to Burkholderia pseudomallei
A case of prostatitis due to Burkholderia pseudomallei
Material Type:
Artigo 		Adicionar ao Meu Espaço

A case of prostatitis due to Burkholderia pseudomallei

Arzola, Jorge M ; Hawley, Joshua S ; Oakman, Crystal ; Mora, Rafael V

Nature clinical practice urology, 2007-02, Vol.4 (2), p.111-114 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem–Cilastatin/Relebactam Combination Therapy
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem–Cilastatin/Relebactam Combination Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Pharmacokinetics and Pharmacodynamics of Imipenem–Cilastatin/Relebactam Combination Therapy

McCarthy, Matthew W.

Clinical pharmacokinetics, 2020-05, Vol.59 (5), p.567-573 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
9
Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach

Ghazi, Islam M ; El Nekidy, Wasim S ; Asay, Regan ; Fingmori, Paul ; Knarr, Anthony ; Awad, Mina Clegg, Simon Russell

PloS one, 2020-05, Vol.15 (5), p.e0233335-e0233335 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
10
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia

Patel, Munjal ; Bellanti, Francesco ; Daryani, Naveen M. ; Noormohamed, Nadia ; Hilbert, David W. ; Young, Katherine ; Kulkarni, Pooja ; Copalu, William ; Gheyas, Ferdous ; Rizk, Matthew L.

Clinical and translational science, 2022-02, Vol.15 (2), p.396-408 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (747)
  2. Revistas revisadas por pares (713)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (757)
  2. Newsletter Articles  (11)
  3. magazinearticle  (3)
  4. Book Chapters  (3)
  5. Resenhas  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1993  (14)
  2. 1993Até2000  (34)
  3. 2001Até2008  (81)
  4. 2009Até2017  (189)
  5. Após 2017  (458)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (767)
  2. Japonês  (55)
  3. Alemão  (5)
  4. Português  (3)
  5. Francês  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.